Capital Link Greece | Investing In Greece

Results: « Previous 1 2 ... 3626 3627 3628 3629 3630 3631 3632 ... 13677 13678 Next »

Market news

Former Yukos investors urge UK High Court to restart legal action

11/10/2022 18:10 - Former owners of what was once Russia’s largest oil company seek to claim a $50bn arbitration award ...

UK grocery inflation climbs to record high of 13.9% in September

11/10/2022 18:10 - Households face increase of £643 in their annual supermarket spend, research by Kantar finds ...

UK pension funds call on Bank of England to extend bond purchases

11/10/2022 18:10 - Industry still faces ‘a lot of disorder’ from LDI strategies at the centre of the crisis ...

Disease and war are shaping our economy

11/10/2022 18:10 - As the new IMF report focuses on continuing downside risks, what can and should be done? ...

Biden to ‘re-evaluate’ Saudi relations after Opec cuts, White House says

11/10/2022 17:10 - Output reduction by oil cartel has inflamed tensions between Washington and Riyadh ...

Markets at risk of ‘disorderly’ sell-off, says IMF

11/10/2022 17:10 - Higher rates and lower growth threaten to expose financial fragilities, according to top Fund official ...

NHS backlogs and Covid leave long-term sick level at record high

11/10/2022 17:10 - ...

: Intellia Therapeutics started at overweight with $84 stock price target at Morgan Stanley

11/10/2022 16:10 - This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. ...

: Crispr Therapeutics started at underweight with $37 stock price target at Morgan Stanley

: Revance Therapeutics started at equal weight with $27 stock price target at Morgan Stanley